Ethylene Oxide Statistics in Queensbury
11
Sterilization Chambers
~180 tons/year
Annual EtO Processed
Sterigenics International
Facility Operator
3 years (personal injury)
New York SOL
Courts in Queensbury, New York
Warren County Supreme Court
1340 State Route 9, Lake George, NY 12845
U.S. District Court — Northern District of New York
100 S Clinton St, Syracuse, NY 13261
Hospitals & Trauma Centers in Queensbury
Glens Falls Hospital — C.R. Wood Cancer Center
100 Park St, Glens Falls, NY 12801
Albany Medical Center — Cancer Center
43 New Scotland Ave, Albany, NY 12208
Liability Considerations in Queensbury
Massive Scale of Queensbury Operations
The Sterigenics Queensbury facility is among the highest-volume EtO sterilization operations in the United States. With 11 sterilization chambers processing approximately 180 tons of ethylene oxide annually, the facility's throughput dwarfs most other EtO operations in the country. This scale of operations is significant for litigation because higher EtO volumes correlate with greater ambient air concentrations in the surrounding community, strengthening plaintiffs' exposure arguments.
The facility is located in Warren County in the Adirondack region of upstate New York — an area known for clean air and outdoor recreation, not industrial emissions. The contrast between the community's expectations and the reality of a major EtO emitter operating in their midst has fueled organized community opposition and media attention that supports the litigation narrative.
Medical Monitoring Claims Under New York Law
New York is one of a limited number of states that recognizes medical monitoring as a compensable claim — allowing individuals who have been exposed to a toxic substance to recover the costs of ongoing medical surveillance even before they are diagnosed with cancer. For Queensbury-area residents, this is a critical legal avenue because many community members have documented EtO exposure (through EPA modeling and ambient air monitoring) but have not yet developed cancer.
Medical monitoring claims allow these exposed individuals to obtain court-ordered funding for regular cancer screenings, blood tests, and other diagnostic procedures that can detect EtO-related cancers at their earliest and most treatable stages. The availability of medical monitoring claims under New York law also expands the potential plaintiff class far beyond individuals who have already been diagnosed with cancer, increasing the litigation's aggregate value and Sterigenics' overall exposure.